These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 33222249)
1. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure. Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME; Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249 [TBL] [Abstract][Full Text] [Related]
2. Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure. Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Muntoni F; Estilow T; Shy ME; Ramchandren S; J Peripher Nerv Syst; 2023 Jun; 28(2):237-251. PubMed ID: 36748295 [TBL] [Abstract][Full Text] [Related]
3. Validation of the parent-proxy version of the pediatric Charcot-Marie-Tooth disease quality of life instrument for children aged 0-7 years. Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Muntoni F; Milev E; Estilow T; Shy ME; Ramchandren S; J Peripher Nerv Syst; 2023 Sep; 28(3):382-389. PubMed ID: 37166413 [TBL] [Abstract][Full Text] [Related]
4. Validation of the Italian version of the pediatric CMT quality of life outcome measure. Moroni I; Danti FR; Pareyson D; Pagliano E; Piscosquito G; Foscan M; Marchi A; Ardissone A; Genitrini S; Wu TT; Shy ME; Ramchandren S J Peripher Nerv Syst; 2022 Jun; 27(2):127-130. PubMed ID: 35416371 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale. Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010 [TBL] [Abstract][Full Text] [Related]
7. Parent-proxy pediatric CMT quality of life outcome measure: Validation of the Italian version. Danti FR; Pagliano E; Pareyson D; Foscan M; Marchi A; Feoli A; Bruschi F; Piscosquito G; Shy ME; Ramchandren S; Moroni I; Wu TT J Peripher Nerv Syst; 2024 Mar; 29(1):107-110. PubMed ID: 38329138 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Italian version of the Charcot-Marie-Tooth Health Index. Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D; J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835 [TBL] [Abstract][Full Text] [Related]
9. The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome. Johnson NE; Heatwole C; Creigh P; McDermott MP; Dilek N; Hung M; Bounsanga J; Tang W; Shy ME; Herrmann DN Ann Neurol; 2018 Aug; 84(2):225-233. PubMed ID: 30014533 [TBL] [Abstract][Full Text] [Related]
10. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale. Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473 [TBL] [Abstract][Full Text] [Related]
11. Reliability of the Charcot-Marie-Tooth functional outcome measure. Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461 [TBL] [Abstract][Full Text] [Related]
15. Development of a functional outcome measure for riboflavin transporter deficiency. Fennessy JR; Donlevy GA; McKay MJ; Burns J; Cornett KMD; Menezes MP J Peripher Nerv Syst; 2024 Jun; 29(2):185-192. PubMed ID: 38445790 [TBL] [Abstract][Full Text] [Related]
16. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life. Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G; Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471 [TBL] [Abstract][Full Text] [Related]
17. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Padua L; Aprile I; Cavallaro T; Commodari I; La Torre G; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A; Neurol Sci; 2006 Dec; 27(6):417-23. PubMed ID: 17205227 [TBL] [Abstract][Full Text] [Related]
18. Effect of pain in pediatric inherited neuropathies. Ramchandren S; Jaiswal M; Feldman E; Shy M Neurology; 2014 Mar; 82(9):793-7. PubMed ID: 24477108 [TBL] [Abstract][Full Text] [Related]
19. Determinants of reduced health-related quality of life in pediatric inherited neuropathies. Burns J; Ramchandren S; Ryan MM; Shy M; Ouvrier RA Neurology; 2010 Aug; 75(8):726-31. PubMed ID: 20733147 [TBL] [Abstract][Full Text] [Related]
20. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Padua L; Cavallaro T; Pareyson D; Quattrone A; Vita G; Schenone A; Neurol Sci; 2008 Jun; 29(3):193-4. PubMed ID: 18612771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]